Allergy, ISSN 0105-4538, 07/2011, Volume 66, Issue 7, pp. 870 - 877
To cite this article: D’Avino R, Bernardi ML, Wallner M, Palazzo P, Camardella L, Tuppo L, Alessandri C, Breiteneder H, Ferreira F, Ciardiello MA, Mari A....
allergen | Act d 11 | kirola | Bet v 1‐like | kiwifruit | Bet v 1-like | FOOD ALLERGENS | MAJOR CELERY ALLERGEN | BIOCHEMICAL-CHARACTERIZATION | IGE-BINDING | IMMUNOLOGY | SITE-DIRECTED MUTAGENESIS | BIRCH POLLEN ALLERGEN | BET V 1 | EPITOPE | ALLERGY | KIWI FRUIT | CROSS-REACTIVITY | Allergens - adverse effects | Fruit - immunology | Humans | Middle Aged | Child, Preschool | Molecular Sequence Data | Male | Actinidia - adverse effects | Antigens, Plant - chemistry | Immunoglobulin E - blood | Young Adult | Food Hypersensitivity - immunology | Allergens - immunology | Plant Proteins - chemistry | Allergens - chemistry | Adult | Female | Food Hypersensitivity - etiology | Child | Amino Acid Sequence | Skin Tests | Austria - epidemiology | Antigens, Plant - immunology | Plant Proteins - immunology | Actinidia - immunology | Food Hypersensitivity - epidemiology | Fruit - adverse effects | Sequence Alignment | Adolescent | Italy - epidemiology | Aged | Food Hypersensitivity - physiopathology | Immunoglobulin E | Allergens | Medical colleges | Food allergy | Protein binding | Proteins | Food allergies | Immunoglobulins | Epidemiology | Fruits | protein families | Bet v 1 antigen | Hypersensitivity | Amino acid sequence | Immunoblotting | Food hypersensitivity | Latex | Skin tests
allergen | Act d 11 | kirola | Bet v 1‐like | kiwifruit | Bet v 1-like | FOOD ALLERGENS | MAJOR CELERY ALLERGEN | BIOCHEMICAL-CHARACTERIZATION | IGE-BINDING | IMMUNOLOGY | SITE-DIRECTED MUTAGENESIS | BIRCH POLLEN ALLERGEN | BET V 1 | EPITOPE | ALLERGY | KIWI FRUIT | CROSS-REACTIVITY | Allergens - adverse effects | Fruit - immunology | Humans | Middle Aged | Child, Preschool | Molecular Sequence Data | Male | Actinidia - adverse effects | Antigens, Plant - chemistry | Immunoglobulin E - blood | Young Adult | Food Hypersensitivity - immunology | Allergens - immunology | Plant Proteins - chemistry | Allergens - chemistry | Adult | Female | Food Hypersensitivity - etiology | Child | Amino Acid Sequence | Skin Tests | Austria - epidemiology | Antigens, Plant - immunology | Plant Proteins - immunology | Actinidia - immunology | Food Hypersensitivity - epidemiology | Fruit - adverse effects | Sequence Alignment | Adolescent | Italy - epidemiology | Aged | Food Hypersensitivity - physiopathology | Immunoglobulin E | Allergens | Medical colleges | Food allergy | Protein binding | Proteins | Food allergies | Immunoglobulins | Epidemiology | Fruits | protein families | Bet v 1 antigen | Hypersensitivity | Amino acid sequence | Immunoblotting | Food hypersensitivity | Latex | Skin tests
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 03/2015, Volume 70, Issue 3, pp. 930 - 940
Objectives: It is still debated if pre-existing minority drug-resistant HIV-1 variants (MVs) affect the virological outcomes of first-line NNRTI-containing...
CHAIN | Minority drug-resistant HIV-1 variants | Pharmacology (medical) | European multicentre study | Infectious Diseases | Pharmacology | Antiretroviral therapy | INFECTIOUS DISEASES | VARIANTS | antiretroviral therapy | REVERSE-TRANSCRIPTASE | MICROBIOLOGY | NEVIRAPINE | BASIC CONCEPTS | THERAPY | POLYMORPHISMS | minority drug-resistant HIV-1 variants | EFAVIRENZ | IMMUNODEFICIENCY-VIRUS TYPE-1 | PHARMACOLOGY & PHARMACY | MUTATIONS | ANTIRETROVIRAL TREATMENT | Original Research
CHAIN | Minority drug-resistant HIV-1 variants | Pharmacology (medical) | European multicentre study | Infectious Diseases | Pharmacology | Antiretroviral therapy | INFECTIOUS DISEASES | VARIANTS | antiretroviral therapy | REVERSE-TRANSCRIPTASE | MICROBIOLOGY | NEVIRAPINE | BASIC CONCEPTS | THERAPY | POLYMORPHISMS | minority drug-resistant HIV-1 variants | EFAVIRENZ | IMMUNODEFICIENCY-VIRUS TYPE-1 | PHARMACOLOGY & PHARMACY | MUTATIONS | ANTIRETROVIRAL TREATMENT | Original Research
Journal Article
The European Physical Journal C, ISSN 1434-6044, 6/2019, Volume 79, Issue 6, pp. 1 - 161
We review the physics opportunities of the Future Circular Collider, covering its e+e-, pp, ep and heavy ion programmes. We describe the measurement...
Nuclear Physics, Heavy Ions, Hadrons | Measurement Science and Instrumentation | Nuclear Energy | Quantum Field Theories, String Theory | Physics | Elementary Particles, Quantum Field Theory | Astronomy, Astrophysics and Cosmology | TRANSVERSE-MOMENTUM | BRANCHING FRACTIONS | ELECTROWEAK PHASE-TRANSITION | BY-LIGHT SCATTERING | TOP-QUARK | DEEP INELASTIC-SCATTERING | E(+)E(-) COLLISIONS | DARK-MATTER | RADIATIVE-CORRECTIONS | STRANGE BARYON PRODUCTION | PHYSICS, PARTICLES & FIELDS | Àrees temàtiques de la UPC | Física | INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND TECHNOLOGY | PARTICLE ACCELERATORS | PHYSICS OF ELEMENTARY PARTICLES AND FIELDS | Fysik | Physical Sciences | Subatomic Physics | Naturvetenskap | Acceleratorfysik och instrumentering | Subatomär fysik | Accelerator Physics and Instrumentation | Natural Sciences
Nuclear Physics, Heavy Ions, Hadrons | Measurement Science and Instrumentation | Nuclear Energy | Quantum Field Theories, String Theory | Physics | Elementary Particles, Quantum Field Theory | Astronomy, Astrophysics and Cosmology | TRANSVERSE-MOMENTUM | BRANCHING FRACTIONS | ELECTROWEAK PHASE-TRANSITION | BY-LIGHT SCATTERING | TOP-QUARK | DEEP INELASTIC-SCATTERING | E(+)E(-) COLLISIONS | DARK-MATTER | RADIATIVE-CORRECTIONS | STRANGE BARYON PRODUCTION | PHYSICS, PARTICLES & FIELDS | Àrees temàtiques de la UPC | Física | INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND TECHNOLOGY | PARTICLE ACCELERATORS | PHYSICS OF ELEMENTARY PARTICLES AND FIELDS | Fysik | Physical Sciences | Subatomic Physics | Naturvetenskap | Acceleratorfysik och instrumentering | Subatomär fysik | Accelerator Physics and Instrumentation | Natural Sciences
Journal Article
Journal of Instrumentation, ISSN 1748-0221, 2012, Volume 7, Issue 3, pp. P03012 - P03012
This paper presents a complete description of Virgo, the French-Italian gravitational wave detector. The detector, built at Cascina, near Pisa (Italy), is a...
Lasers | Antennas | Suspensions | Interferometry | SYSTEM | PROTOTYPE | ANTENNA | SUSPENSION | 1ST | INSTRUMENTS & INSTRUMENTATION | SCATTERED-LIGHT NOISE | SUPER ATTENUATOR | SHOT-NOISE | PENDULUM | SEISMIC NOISE | Specifications | Gravitational waves | Detectors | Electronics | Instrumentation | Optical components | Interferometers | General Relativity and Quantum Cosmology | Sciences of the Universe | Astrophysics | Physics | Instrumentation and Methods for Astrophysic
Lasers | Antennas | Suspensions | Interferometry | SYSTEM | PROTOTYPE | ANTENNA | SUSPENSION | 1ST | INSTRUMENTS & INSTRUMENTATION | SCATTERED-LIGHT NOISE | SUPER ATTENUATOR | SHOT-NOISE | PENDULUM | SEISMIC NOISE | Specifications | Gravitational waves | Detectors | Electronics | Instrumentation | Optical components | Interferometers | General Relativity and Quantum Cosmology | Sciences of the Universe | Astrophysics | Physics | Instrumentation and Methods for Astrophysic
Journal Article
The European Physical Journal. C, Particles and Fields, ISSN 1434-6044, 06/2019, Volume 79, Issue 6, pp. 1 - 161
We review the physics opportunities of the Future Circular Collider, covering its e+e-, pp, ep and heavy ion programmes. We describe the measurement...
Standard model (particle physics) | Quarks | Heavy ions | Physics
Standard model (particle physics) | Quarks | Heavy ions | Physics
Journal Article
BMC nephrology, ISSN 1471-2369, 2014, Volume 15, Issue 1, pp. 51 - 51
No consensus exists on how to define abnormally rapid deterioration in renal function (Rapid Progression, RP). We developed an operational definition of RP in...
Kidney disease | Chronic kidney disease | HIV | Estimated glomerular filtration rate | Rapid progression | POPULATION | MORTALITY RISK | BODY-SURFACE AREA | ANTIRETROVIRAL THERAPY | INDIVIDUALS | GLOMERULAR-FILTRATION-RATE | FUNCTION DECLINE | UROLOGY & NEPHROLOGY | INFECTED PATIENTS | CHRONIC KIDNEY-DISEASE | ASSOCIATION | Severity of Illness Index | Reproducibility of Results | Glomerular Filtration Rate | Humans | Middle Aged | Male | Renal Insufficiency, Chronic - complications | Disease Progression | Algorithms | Internationality | HIV Infections - diagnosis | Sensitivity and Specificity | Diagnosis, Computer-Assisted - methods | HIV Infections - complications | Aged, 80 and over | Adult | Female | Renal Insufficiency, Chronic - diagnosis | Aged | Medical research | Usage | Analysis | Medicine, Experimental | Biological products industry | Pharmaceutical industry | Data entry | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Colleges & universities | Rheumatology | Population | Infections | Kidney diseases | Risk factors | Malalties del ronyó | HIV infections | Chronic renal failure | VIH (Virus) | Infeccions per VIH | HIV (Viruses) | Insuficiència renal crònica | Life Sciences | Microbiology and Parasitology
Kidney disease | Chronic kidney disease | HIV | Estimated glomerular filtration rate | Rapid progression | POPULATION | MORTALITY RISK | BODY-SURFACE AREA | ANTIRETROVIRAL THERAPY | INDIVIDUALS | GLOMERULAR-FILTRATION-RATE | FUNCTION DECLINE | UROLOGY & NEPHROLOGY | INFECTED PATIENTS | CHRONIC KIDNEY-DISEASE | ASSOCIATION | Severity of Illness Index | Reproducibility of Results | Glomerular Filtration Rate | Humans | Middle Aged | Male | Renal Insufficiency, Chronic - complications | Disease Progression | Algorithms | Internationality | HIV Infections - diagnosis | Sensitivity and Specificity | Diagnosis, Computer-Assisted - methods | HIV Infections - complications | Aged, 80 and over | Adult | Female | Renal Insufficiency, Chronic - diagnosis | Aged | Medical research | Usage | Analysis | Medicine, Experimental | Biological products industry | Pharmaceutical industry | Data entry | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Colleges & universities | Rheumatology | Population | Infections | Kidney diseases | Risk factors | Malalties del ronyó | HIV infections | Chronic renal failure | VIH (Virus) | Infeccions per VIH | HIV (Viruses) | Insuficiència renal crònica | Life Sciences | Microbiology and Parasitology
Journal Article
ATHEROSCLEROSIS, ISSN 0021-9150, 11/2018, Volume 278, pp. 49 - 59
Mineral bone disease (MBD) is a common complication of chronic kidney disease (CKD) characterized by disruption of normal mineral homeostasis within the body....
VITAMIN-D | CARDIAC & CARDIOVASCULAR SYSTEMS | MORTALITY RISK | CARDIOVASCULAR CALCIFICATIONS | CKD-MBD | D-RECEPTOR ACTIVATORS | CORONARY CALCIFICATION | Vitamin D | Phosphate | Atherosclerosis | Vascular calcification | HEMODIALYSIS-PATIENTS | PERIPHERAL VASCULAR DISEASE | PHOSPHATE BINDERS | CHRONIC KIDNEY-DISEASE | STAGE RENAL-DISEASE
VITAMIN-D | CARDIAC & CARDIOVASCULAR SYSTEMS | MORTALITY RISK | CARDIOVASCULAR CALCIFICATIONS | CKD-MBD | D-RECEPTOR ACTIVATORS | CORONARY CALCIFICATION | Vitamin D | Phosphate | Atherosclerosis | Vascular calcification | HEMODIALYSIS-PATIENTS | PERIPHERAL VASCULAR DISEASE | PHOSPHATE BINDERS | CHRONIC KIDNEY-DISEASE | STAGE RENAL-DISEASE
Journal Article
Heart, ISSN 1355-6037, 02/2017, Volume 103, Issue 4, pp. 307 - 314
ObjectiveWe studied evolving antithrombotic therapy patterns in patients with newly diagnosed non-valvular atrial fibrillation (AF) and ≥1 additional stroke...
CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | STROKE PREVENTION | RISK-FACTOR | WARFARIN | TRANSIENT ISCHEMIC ATTACK | GLOBAL ANTICOAGULANT REGISTRY | GUIDELINES | EURO HEART SURVEY | SUBGROUP ANALYSIS | THROMBOEMBOLISM | Prospective Studies | Age Factors | Humans | Middle Aged | Stroke - diagnosis | Male | Fibrinolytic Agents - adverse effects | Time Factors | Aged, 80 and over | Female | Registries | Stroke - epidemiology | Atrial Fibrillation - diagnosis | Stroke - prevention & control | Risk Assessment | Administration, Oral | Atrial Fibrillation - drug therapy | Comorbidity | Risk Factors | Treatment Outcome | Practice Patterns, Physicians' - trends | Guideline Adherence | Atrial Fibrillation - epidemiology | Sex Factors | Aged | Fibrinolytic Agents - administration & dosage | Practice Guidelines as Topic | Stroke (Disease) | Care and treatment | Usage | Atrial fibrillation | Diagnosis | Thrombolytic drugs | Patients | Health aspects | Risk factors | Arrhythmias and Sudden Death | 1506 | Stroke
CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | STROKE PREVENTION | RISK-FACTOR | WARFARIN | TRANSIENT ISCHEMIC ATTACK | GLOBAL ANTICOAGULANT REGISTRY | GUIDELINES | EURO HEART SURVEY | SUBGROUP ANALYSIS | THROMBOEMBOLISM | Prospective Studies | Age Factors | Humans | Middle Aged | Stroke - diagnosis | Male | Fibrinolytic Agents - adverse effects | Time Factors | Aged, 80 and over | Female | Registries | Stroke - epidemiology | Atrial Fibrillation - diagnosis | Stroke - prevention & control | Risk Assessment | Administration, Oral | Atrial Fibrillation - drug therapy | Comorbidity | Risk Factors | Treatment Outcome | Practice Patterns, Physicians' - trends | Guideline Adherence | Atrial Fibrillation - epidemiology | Sex Factors | Aged | Fibrinolytic Agents - administration & dosage | Practice Guidelines as Topic | Stroke (Disease) | Care and treatment | Usage | Atrial fibrillation | Diagnosis | Thrombolytic drugs | Patients | Health aspects | Risk factors | Arrhythmias and Sudden Death | 1506 | Stroke
Journal Article
European Heart Journal, ISSN 0195-668X, 10/2016, Volume 37, Issue 38, pp. 2882 - 2889A
The relationship between outcomes and time after diagnosis for patients with non-valvular atrial fibrillation (NVAF) is poorly defined, especially beyond the...
Stroke prevention | Stroke | Anticoagulation | Atrial fibrillation | Bleeding | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | PREVENTION | DEATH | PREVALENCE | RISK STRATIFICATION SCHEMES | ANTITHROMBOTIC TREATMENT | RHYTHM MANAGEMENT | REGISTRY | Clinical Research
Stroke prevention | Stroke | Anticoagulation | Atrial fibrillation | Bleeding | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | PREVENTION | DEATH | PREVALENCE | RISK STRATIFICATION SCHEMES | ANTITHROMBOTIC TREATMENT | RHYTHM MANAGEMENT | REGISTRY | Clinical Research
Journal Article